Report Detail
Global Circulating Tumor Cell Detection Instrument Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4686339 |
- 17 June, 2026 |
- Global |
- 86 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Circulating Tumor Cell Detection Instrument market size was valued at US$ 1008 million in 2025 and is forecast to a readjusted size of US$ 1757 million by 2032 with a CAGR of 8.1% during review period.
A circulating tumor cell (CTC) detection instrument is an advanced medical diagnostic device used to identify and analyze circulating tumor cells in peripheral blood. These systems utilize microfluidics, immunomagnetic separation, and imaging or molecular detection technologies to enable early cancer diagnosis, prognostic assessment, and treatment monitoring, thereby supporting precision oncology applications. The CTC detection instrument industry chain includes several key segments. The upstream mainly covers the supply of core components and consumables such as antibody materials, microfluidic chips, optical detection modules, biological reagents, and sensors. The midstream involves equipment research and development and manufacturing, including sample processing system design, cell capture technology development, detection algorithm integration, and overall assembly and calibration. Downstream applications are mainly concentrated in hospitals, cancer research institutions, and in vitro diagnostic laboratories for early cancer screening, efficacy monitoring, and recurrence risk assessment. The industry chain also includes clinical trial support, data analysis services, and medical certification systems to ensure the accuracy of test results and their clinical application value. In 2025, global Circulating Tumor Cell Detection Instrument production reached approximately 20.4 thousand units, with an average global market price of around US$ 48,000 per unit.The gross profit margin of major companies in the industry is between 45% – 72%.In 2025, the global production capacity of circulating tumor cell detection instruments was approximately 27.2 thousand units.
The Circulating Tumor Cell Detection Instrument market is a high-growth segment within the in-vitro diagnostics and precision oncology industry, driven by increasing cancer incidence and demand for early detection technologies. These instruments enable non-invasive cancer diagnosis and real-time monitoring of treatment response by detecting rare tumor cells in peripheral blood. Market growth is supported by advancements in microfluidics, immunoassay technologies, and molecular diagnostics, as well as increasing adoption of personalized medicine. However, the market faces challenges such as high equipment costs, complex clinical validation processes, and variability in detection sensitivity. Overall, the industry demonstrates strong long-term growth potential, closely linked to the expansion of precision medicine and oncology diagnostic innovation.
This report is a detailed and comprehensive analysis for global Circulating Tumor Cell Detection Instrument market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Circulating Tumor Cell Detection Instrument market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Circulating Tumor Cell Detection Instrument market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Circulating Tumor Cell Detection Instrument market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Circulating Tumor Cell Detection Instrument market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Circulating Tumor Cell Detection Instrument
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Circulating Tumor Cell Detection Instrument market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Menarini-Silicon Biosystems, Fluxion Biosciences, HangZhou Watson Biotech Co.,Ltd, ANGLE plc, Sartorius, ApoStream（ApoCell）, Ikonisys, Epic Sciences, Biocept, Sysmex, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Circulating Tumor Cell Detection Instrument market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
RNA-based Techniques
Microfluidic Chips-based Techniques
Immunostaining and Immunofluorescence Labeling-based Techniques
Other
Market segment by Detection Sensitivity
Low Sensitivity: ≥10 CTCs/mL
Standard Sensitivity: 1–10 CTCs/mL
High Sensitivity: 0.1–1 CTC/mL
Ultra-high Sensitivity: ≤0.1 CTC/mL
Market segment by Enrichment Method
Positive Enrichment CTC System
Negative Depletion CTC Detection System
Market segment by Application
Drug R&D Institutions and Laboratories
Hospital
Other
Major players covered
Menarini-Silicon Biosystems
Fluxion Biosciences
HangZhou Watson Biotech Co.,Ltd
ANGLE plc
Sartorius
ApoStream（ApoCell）
Ikonisys
Epic Sciences
Biocept
Sysmex
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Circulating Tumor Cell Detection Instrument product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Circulating Tumor Cell Detection Instrument, with price, sales quantity, revenue, and global market share of Circulating Tumor Cell Detection Instrument from 2021 to 2026.
Chapter 3, the Circulating Tumor Cell Detection Instrument competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Circulating Tumor Cell Detection Instrument breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Circulating Tumor Cell Detection Instrument market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Circulating Tumor Cell Detection Instrument.
Chapter 14 and 15, to describe Circulating Tumor Cell Detection Instrument sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Circulating Tumor Cell Detection Instrument Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 RNA-based Techniques
- 1.3.3 Microfluidic Chips-based Techniques
- 1.3.4 Immunostaining and Immunofluorescence Labeling-based Techniques
- 1.3.5 Other
- 1.4 Market Analysis by Detection Sensitivity
- 1.4.1 Overview: Global Circulating Tumor Cell Detection Instrument Consumption Value by Detection Sensitivity: 2021 Versus 2025 Versus 2032
- 1.4.2 Low Sensitivity: ≥10 CTCs/mL
- 1.4.3 Standard Sensitivity: 1–10 CTCs/mL
- 1.4.4 High Sensitivity: 0.1–1 CTC/mL
- 1.4.5 Ultra-high Sensitivity: ≤0.1 CTC/mL
- 1.5 Market Analysis by Enrichment Method
- 1.5.1 Overview: Global Circulating Tumor Cell Detection Instrument Consumption Value by Enrichment Method: 2021 Versus 2025 Versus 2032
- 1.5.2 Positive Enrichment CTC System
- 1.5.3 Negative Depletion CTC Detection System
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Circulating Tumor Cell Detection Instrument Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Drug R&D Institutions and Laboratories
- 1.6.3 Hospital
- 1.6.4 Other
- 1.7 Global Circulating Tumor Cell Detection Instrument Market Size & Forecast
- 1.7.1 Global Circulating Tumor Cell Detection Instrument Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Circulating Tumor Cell Detection Instrument Sales Quantity (2021-2032)
- 1.7.3 Global Circulating Tumor Cell Detection Instrument Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Menarini-Silicon Biosystems
- 2.1.1 Menarini-Silicon Biosystems Details
- 2.1.2 Menarini-Silicon Biosystems Major Business
- 2.1.3 Menarini-Silicon Biosystems Circulating Tumor Cell Detection Instrument Product and Services
- 2.1.4 Menarini-Silicon Biosystems Circulating Tumor Cell Detection Instrument Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Menarini-Silicon Biosystems Recent Developments/Updates
- 2.2 Fluxion Biosciences
- 2.2.1 Fluxion Biosciences Details
- 2.2.2 Fluxion Biosciences Major Business
- 2.2.3 Fluxion Biosciences Circulating Tumor Cell Detection Instrument Product and Services
- 2.2.4 Fluxion Biosciences Circulating Tumor Cell Detection Instrument Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Fluxion Biosciences Recent Developments/Updates
- 2.3 HangZhou Watson Biotech Co.,Ltd
- 2.3.1 HangZhou Watson Biotech Co.,Ltd Details
- 2.3.2 HangZhou Watson Biotech Co.,Ltd Major Business
- 2.3.3 HangZhou Watson Biotech Co.,Ltd Circulating Tumor Cell Detection Instrument Product and Services
- 2.3.4 HangZhou Watson Biotech Co.,Ltd Circulating Tumor Cell Detection Instrument Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 HangZhou Watson Biotech Co.,Ltd Recent Developments/Updates
- 2.4 ANGLE plc
- 2.4.1 ANGLE plc Details
- 2.4.2 ANGLE plc Major Business
- 2.4.3 ANGLE plc Circulating Tumor Cell Detection Instrument Product and Services
- 2.4.4 ANGLE plc Circulating Tumor Cell Detection Instrument Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 ANGLE plc Recent Developments/Updates
- 2.5 Sartorius
- 2.5.1 Sartorius Details
- 2.5.2 Sartorius Major Business
- 2.5.3 Sartorius Circulating Tumor Cell Detection Instrument Product and Services
- 2.5.4 Sartorius Circulating Tumor Cell Detection Instrument Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Sartorius Recent Developments/Updates
- 2.6 ApoStream（ApoCell）
- 2.6.1 ApoStream（ApoCell） Details
- 2.6.2 ApoStream（ApoCell） Major Business
- 2.6.3 ApoStream（ApoCell） Circulating Tumor Cell Detection Instrument Product and Services
- 2.6.4 ApoStream（ApoCell） Circulating Tumor Cell Detection Instrument Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 ApoStream（ApoCell） Recent Developments/Updates
- 2.7 Ikonisys
- 2.7.1 Ikonisys Details
- 2.7.2 Ikonisys Major Business
- 2.7.3 Ikonisys Circulating Tumor Cell Detection Instrument Product and Services
- 2.7.4 Ikonisys Circulating Tumor Cell Detection Instrument Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Ikonisys Recent Developments/Updates
- 2.8 Epic Sciences
- 2.8.1 Epic Sciences Details
- 2.8.2 Epic Sciences Major Business
- 2.8.3 Epic Sciences Circulating Tumor Cell Detection Instrument Product and Services
- 2.8.4 Epic Sciences Circulating Tumor Cell Detection Instrument Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Epic Sciences Recent Developments/Updates
- 2.9 Biocept
- 2.9.1 Biocept Details
- 2.9.2 Biocept Major Business
- 2.9.3 Biocept Circulating Tumor Cell Detection Instrument Product and Services
- 2.9.4 Biocept Circulating Tumor Cell Detection Instrument Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Biocept Recent Developments/Updates
- 2.10 Sysmex
- 2.10.1 Sysmex Details
- 2.10.2 Sysmex Major Business
- 2.10.3 Sysmex Circulating Tumor Cell Detection Instrument Product and Services
- 2.10.4 Sysmex Circulating Tumor Cell Detection Instrument Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Sysmex Recent Developments/Updates
3 Competitive Environment: Circulating Tumor Cell Detection Instrument by Manufacturer
- 3.1 Global Circulating Tumor Cell Detection Instrument Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Circulating Tumor Cell Detection Instrument Revenue by Manufacturer (2021-2026)
- 3.3 Global Circulating Tumor Cell Detection Instrument Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Circulating Tumor Cell Detection Instrument by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Circulating Tumor Cell Detection Instrument Manufacturer Market Share in 2025
- 3.4.3 Top 6 Circulating Tumor Cell Detection Instrument Manufacturer Market Share in 2025
- 3.5 Circulating Tumor Cell Detection Instrument Market: Overall Company Footprint Analysis
- 3.5.1 Circulating Tumor Cell Detection Instrument Market: Region Footprint
- 3.5.2 Circulating Tumor Cell Detection Instrument Market: Company Product Type Footprint
- 3.5.3 Circulating Tumor Cell Detection Instrument Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Circulating Tumor Cell Detection Instrument Market Size by Region
- 4.1.1 Global Circulating Tumor Cell Detection Instrument Sales Quantity by Region (2021-2032)
- 4.1.2 Global Circulating Tumor Cell Detection Instrument Consumption Value by Region (2021-2032)
- 4.1.3 Global Circulating Tumor Cell Detection Instrument Average Price by Region (2021-2032)
- 4.2 North America Circulating Tumor Cell Detection Instrument Consumption Value (2021-2032)
- 4.3 Europe Circulating Tumor Cell Detection Instrument Consumption Value (2021-2032)
- 4.4 Asia-Pacific Circulating Tumor Cell Detection Instrument Consumption Value (2021-2032)
- 4.5 South America Circulating Tumor Cell Detection Instrument Consumption Value (2021-2032)
- 4.6 Middle East & Africa Circulating Tumor Cell Detection Instrument Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Circulating Tumor Cell Detection Instrument Sales Quantity by Type (2021-2032)
- 5.2 Global Circulating Tumor Cell Detection Instrument Consumption Value by Type (2021-2032)
- 5.3 Global Circulating Tumor Cell Detection Instrument Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Circulating Tumor Cell Detection Instrument Sales Quantity by Application (2021-2032)
- 6.2 Global Circulating Tumor Cell Detection Instrument Consumption Value by Application (2021-2032)
- 6.3 Global Circulating Tumor Cell Detection Instrument Average Price by Application (2021-2032)
7 North America
- 7.1 North America Circulating Tumor Cell Detection Instrument Sales Quantity by Type (2021-2032)
- 7.2 North America Circulating Tumor Cell Detection Instrument Sales Quantity by Application (2021-2032)
- 7.3 North America Circulating Tumor Cell Detection Instrument Market Size by Country
- 7.3.1 North America Circulating Tumor Cell Detection Instrument Sales Quantity by Country (2021-2032)
- 7.3.2 North America Circulating Tumor Cell Detection Instrument Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Circulating Tumor Cell Detection Instrument Sales Quantity by Type (2021-2032)
- 8.2 Europe Circulating Tumor Cell Detection Instrument Sales Quantity by Application (2021-2032)
- 8.3 Europe Circulating Tumor Cell Detection Instrument Market Size by Country
- 8.3.1 Europe Circulating Tumor Cell Detection Instrument Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Circulating Tumor Cell Detection Instrument Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Circulating Tumor Cell Detection Instrument Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Circulating Tumor Cell Detection Instrument Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Circulating Tumor Cell Detection Instrument Market Size by Region
- 9.3.1 Asia-Pacific Circulating Tumor Cell Detection Instrument Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Circulating Tumor Cell Detection Instrument Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Circulating Tumor Cell Detection Instrument Sales Quantity by Type (2021-2032)
- 10.2 South America Circulating Tumor Cell Detection Instrument Sales Quantity by Application (2021-2032)
- 10.3 South America Circulating Tumor Cell Detection Instrument Market Size by Country
- 10.3.1 South America Circulating Tumor Cell Detection Instrument Sales Quantity by Country (2021-2032)
- 10.3.2 South America Circulating Tumor Cell Detection Instrument Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Circulating Tumor Cell Detection Instrument Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Circulating Tumor Cell Detection Instrument Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Circulating Tumor Cell Detection Instrument Market Size by Country
- 11.3.1 Middle East & Africa Circulating Tumor Cell Detection Instrument Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Circulating Tumor Cell Detection Instrument Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Circulating Tumor Cell Detection Instrument Market Drivers
- 12.2 Circulating Tumor Cell Detection Instrument Market Restraints
- 12.3 Circulating Tumor Cell Detection Instrument Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Circulating Tumor Cell Detection Instrument and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Circulating Tumor Cell Detection Instrument
- 13.3 Circulating Tumor Cell Detection Instrument Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Circulating Tumor Cell Detection Instrument Typical Distributors
- 14.3 Circulating Tumor Cell Detection Instrument Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Circulating Tumor Cell Detection Instrument. Industry analysis & Market Report on Circulating Tumor Cell Detection Instrument is a syndicated market report, published as Global Circulating Tumor Cell Detection Instrument Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Circulating Tumor Cell Detection Instrument market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
